Literature DB >> 6384619

Pathology of fetal congenital nephrosis: immunohistochemical and ultrastructural studies.

J Rapola, H Sariola, P Ekblom.   

Abstract

The kidneys of four human fetuses aged 18 to 20 weeks of gestation with congenital nephrosis of the Finnish type (CNF) were studied by immunohistochemistry and electron microscopy to elucidate the pathogenesis of the disease. The immunohistochemical stainings for laminin, type IV collagen, fibronectin, brushborder antigens (BBA), Tamm-Horsfall protein (TH), and binding of wheat germ agglutinin (WGA) did not reveal changes as compared to the age-matched control kidneys. Proximal tubules of the CNF kidneys showed excessive accumulation of coarse granular alpha fetoprotein (AFP) and large absorption droplets with paracrystalline and membraneous structures were seen in electron microscopy. The dilated tubules were both of proximal and distal origin as judged from the BBA and TH stainings. It is suggested that the formation of the dilated tubules results from degeneration caused by obstruction and excessive protein loading of the tubular epithelium. Demonstration of the coarse granular AFP in the proximal tubular epithelium and lumina indicates heavy fetal proteinuria and serves as an additional diagnostic marker for prenatal CNF.

Entities:  

Mesh:

Year:  1984        PMID: 6384619     DOI: 10.1038/ki.1984.77

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.

Authors:  Eduardo Machuca; Geneviève Benoit; Fabien Nevo; Marie-Josèphe Tête; Olivier Gribouval; Audrey Pawtowski; Per Brandström; Chantal Loirat; Patrick Niaudet; Marie-Claire Gubler; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

2.  Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney.

Authors:  H Holthöfer; H Ahola; M L Solin; S Wang; T Palmen; P Luimula; A Miettinen; D Kerjaschki
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 3.  Adrenal calcification and congenital nephrotic syndrome in three American Indians.

Authors:  R J Powers; M L Cohen; J Williams
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

Review 4.  Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations.

Authors:  Geneviève Benoit; Eduardo Machuca; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2010-03-24       Impact factor: 3.714

5.  Congenital nephrosis of the Finnish type (CNF): matrix components of the glomerular basement membranes and of cultured mesangial cells.

Authors:  P Ljungberg; H Jalanko; C Holmberg; H Holthöfer
Journal:  Histochem J       Date:  1993-09

6.  The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type.

Authors:  L P Van den Heuvel; J Van den Born; H Jalanko; C H Schröder; J H Veerkamp; K J Assmann; J H Berden; C Holmberg; J Rapola; L A Monnens
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

Review 7.  Congenital nephrotic syndrome.

Authors:  J Rapola
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

8.  Glycosaminoglycans in urine and amniotic fluid in congenital nephrotic syndrome of the Finnish type.

Authors:  P Ljungberg
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

9.  Localization of extracellular matrix components in congenital nephrotic syndromes.

Authors:  A G Nerlich; I Wiest; E D Schleicher
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

10.  Mutation analysis of NPHS1 in a worldwide cohort of congenital nephrotic syndrome patients.

Authors:  Bugsu Ovunc; Shazia Ashraf; Virginia Vega-Warner; Detlef Bockenhauer; Neveen A Soliman Elshakhs; Mark Joseph; Friedhelm Hildebrandt
Journal:  Nephron Clin Pract       Date:  2012-05-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.